Literature DB >> 3389866

Home intravenous antibiotic treatment in cystic fibrosis.

J Gilbert1, T Robinson, J M Littlewood.   

Abstract

The prognosis for patients with cystic fibrosis who are colonised with Pseudomonas aeruginosa has improved as a result of the regular use of intravenous antibiotics; however, this necessitates long periods of hospitalisation. Home intravenous antibiotic treatment has potential advantages over hospital treatment. We describe our experience during the first 20 months of using a system of home intravenous antibiotic treatment in which a cystic fibrosis liaison sister has an essential role. Thirteen patients have received 40 courses of treatment. There were highly significant improvements in weight, respiratory function, and white cell count during home treatment. There was no significant difference in weight and forced expiratory volume in one second between the end of home treatment and the end of hospital treatment while forced vital capacity was better after home treatment. All patients preferred home treatment. The advantages of home visits by the cystic fibrosis liaison sister during treatment are emphasised.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3389866      PMCID: PMC1778934          DOI: 10.1136/adc.63.5.512

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre.

Authors:  S S Pedersen; C Koch; N Høiby; K Rosendal
Journal:  J Antimicrob Chemother       Date:  1986-04       Impact factor: 5.790

2.  Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock.

Authors:  O Idsoe; T Guthe; R R Willcox; A L de Weck
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

3.  The captive mother.

Authors:  S R Meadow
Journal:  Arch Dis Child       Date:  1969-06       Impact factor: 3.791

4.  Costs of visiting babies in special care baby units.

Authors:  M A Smith; J D Baum
Journal:  Arch Dis Child       Date:  1983-01       Impact factor: 3.791

Review 5.  Antibiotic use in cystic fibrosis.

Authors:  H W Kelly; C Lovato
Journal:  Drug Intell Clin Pharm       Date:  1984-10

6.  Implantable central venous access system.

Authors:  A Bothe; W Piccione; J J Ambrosino; P N Benotti; J J Lokich
Journal:  Am J Surg       Date:  1984-04       Impact factor: 2.565

7.  Self-administered home intravenous antibiotic therapy in bronchiectasis and adult cystic fibrosis.

Authors:  R J Winter; R J George; S J Deacock; C D Shee; D M Geddes
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

8.  Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection.

Authors:  M Szaff; N Høiby; E W Flensborg
Journal:  Acta Paediatr Scand       Date:  1983-09

9.  Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis.

Authors:  E E Wang; C G Prober; B Manson; M Corey; H Levison
Journal:  N Engl J Med       Date:  1984-12-27       Impact factor: 91.245

10.  Feasibility and cost savings of intravenous administration of aminoglycosides in outpatients with cystic fibrosis.

Authors:  J A Bosso; S E Stephenson; J J Herbst
Journal:  Drug Intell Clin Pharm       Date:  1985-01
  10 in total
  15 in total

1.  British Thoracic Society summer meeting. 11-13 July 1990, Birmingham. Abstracts.

Authors: 
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

2.  An integrated child health service.

Authors:  D M Hall; M Prendergast
Journal:  BMJ       Date:  1990-12-15

Review 3.  Intravenous antibiotics at home in children with cystic fibrosis.

Authors:  T J David
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

4.  Intramural and extramural health care in the United Kingdom.

Authors:  P R Noyce
Journal:  Pharm Weekbl Sci       Date:  1990-02-23

5.  An audit of the effect of intravenous antibiotic treatment on spirometric measures of pulmonary function in cystic fibrosis.

Authors:  J M Bradley; E S Wallace; J S Elborn; J L Howard; M P McCoy
Journal:  Ir J Med Sci       Date:  1999 Jan-Mar       Impact factor: 1.568

6.  [Cost comparison of hospital and ambulatory i.v. therapy in adult cystic fibrosis patients. Results of a controlled prospective study].

Authors:  C Krauth; R Busse; C Smaczny; G Ullrich; T O Wagner; J Weber; T Welte
Journal:  Med Klin (Munich)       Date:  1999-10-15

Review 7.  Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies.

Authors:  Christian Krauth; Noushin Jalilvand; Tobias Welte; Reinhard Busse
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 8.  Quality of life in children and adolescents with cystic fibrosis: implications for optimizing treatments and clinical trial design.

Authors:  Janice Abbott; Louise Gee
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Outcomes and Safety of Outpatient Parenteral Antimicrobial Therapy in Select Children with Cystic Fibrosis.

Authors:  Gulnur Com; Amit Agarwal; Shasha Bai; Zhuopei Hu; Grace Goode; Hollyn McCarty; Ariel Berlinski
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2019-12-11       Impact factor: 1.349

10.  Home intravenous antibiotic treatment for acute pulmonary exacerbations in cystic fibrosis - Is it good for the patient?

Authors:  Iara Maria Sequeiros; Nabil A Jarad
Journal:  Ann Thorac Med       Date:  2009-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.